Skip to evidence report

ASPC.adipocyte_capillary_interface: Studies — page 7

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 1,040 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 6,001–7,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.adipocyte_capillary_interface
#Trait / studyIndividual trait IDMean IC score
6001Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T290ECGU0002900.31
6002Blood cell traits latent factor 3 (white cell)GCST905592450.31
6003PDGFA/USP8 ratioGCST903156210.31
6004T1 FreeSurfer DKT lh precentral thicknessGCST903842460.31
6005Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T138ECGU0001380.31
6006Free cholesterol levels in chylomicrons and extremely large VLDLGCST905009650.31
6007Triglyceride levels in VLDLGCST900930030.31
6008Pyruvate levels (UKB data field 23472)GCST902695690.31
6009Cholesterol in Medium VLDLGCST904989030.31
6010Status post-amiFING000013330.31
6011Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)FING000008770.31
6012T1 FreeSurfer aseg Left-PallidumGCST903841460.31
6013LAT2 levelsGCST904697390.31
6014Triglycerides in small VLDL (UKB data field 23515)GCST902696120.31
6015LAT/SPARC ratioGCST903152880.31
6016Phospholipids in IDLGCST904976260.31
6017VSIG2 levelsGCST904710510.31
6018Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders (more control exclusions)FING000001010.31
6019IDP dMRI ProbtrackX ICVF fmiGCST900043860.31
6020Left-hemisphere control network to pallidum white-matter structural connectivityGCST903027550.31
6021Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685260.31
6022Blood cell traits latent factor 9 (white cell)GCST905592510.31
6023VNN1 levelsGCST904710430.30
6024AXIN1/CALCOCO1 ratioGCST903134020.30
6025Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027030.30
6026SCGB1A1 levelsGCST904705400.30
6027Frequency of drinking alcohol | Alcohol useUKBB000002600.30
6028CASP8/SEPTIN9 ratioGCST903136580.30
6029Phenylalanine levelsGCST904992230.30
6030ICD10 N92: Excessive, frequent and irregular menstruationGCST904542210.30
6031IDP dMRI TBSS FA Anterior limb of internal capsule RGCST900038930.30
6032IKBKG levelsGCST904695420.30
6033CDSN/NECTIN4 ratioGCST903139980.30
6034Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366ECGA0003660.30
6035T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST903206390.30
6036GART levelsGCST904693030.30
6037SORCS2 levelsGCST904707080.30
6038Hypertensive chronic kidney disease (PheCode 401.22)GCST904759270.30
6039NRAC levelsGCST906179910.30
6040IDP dMRI TBSS ICVF Cingulum cingulate gyrus RGCST900043610.30
6041GFER/MAVS ratioGCST903149190.30
6042SUMF1 levelsGCST904707830.30
6043Total fatty acid levelsGCST905027110.30
6044ESAM/VSIR ratioGCST903147210.30
6045Osteoarthritis (hip)GCST0070910.30
6046Phospholipids in VLDLGCST905002660.30
6047Triglycerides to Total Lipids in Large LDL percentageGCST904981010.30
6048IDP dMRI TBSS ICVF Inferior cerebellar peduncle RGCST900043370.30
6049Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T407ECGU0004070.30
6050Saturated fatty acids levelsGCST905026740.30
6051DKK1/VEGFC ratioGCST903144840.30
6052Total testosterone levelsGCST902398190.30
6053Cerotoylcarnitine (C26) levelsGCST902001360.30
6054Cholesterol levels in medium HDLGCST900928920.30
6055ECHS1 levelsGCST904690630.30
6056Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T298ECGA0002980.30
6057total creatine kinase (maximum, inv-norm transformed)GCST904764100.30
6058Other non-toxic goitre | Disorders of thyroid glandUKBB000006170.30
6059Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T193ECGU0001930.30
6060Erythematous conditions (PheCode 695)GCST904761770.30
6061MMP3 levelsGCST900120270.30
6062CCL2 levelsGCST900120070.30
6063AsthmaGCST900860470.30
6064Triglycerides to Total Lipids in Medium LDL percentageGCST904988850.30
6065Major dietary changes in the last 5 years - No | DietUKBB000004210.30
6066Champagne or white wine consumption (glasses per month) (UKB data field 1578, 4418)GCST901329860.30
6067CAG-776 abundance in stoolGCST900322970.30
6068Free cholesterol to total lipids in large LDL percentage (UKB data field 23617)GCST902697140.30
6069Alcohol-related disorders | mental disordersUKBB000000260.30
6070Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900245040.30
6071Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T399ECGU0003990.30
6072GNPDA2 levelsGCST904693740.29
6073Volume of left lateral nucleusGCST904748890.29
6074Microscopic polyangiitisFING000008170.29
6075Ever sought or received professional help for mental distress | Mental distressUKBB000002220.29
6076Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T194ECGU0001940.29
6077C1S levelsGCST904684940.29
6078Cholesteryl ester levels in large VLDLGCST900928700.29
6079Total fatty acid levelsGCST905027270.29
6080CNTN3 levelsGCST904688050.29
6081Acid reflux/GERDGCST904753200.29
6082Phosphatidylcholine-2O_32:0_[M+H]1+ levelsGCST900602440.29
6083CLEC1B/MPIG6B ratioGCST903140980.29
6084GAL/PM20D1 ratioGCST903149170.29
6085Free Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007980.29
6086IDP dMRI TBSS L3 Anterior limb of internal capsule RGCST900041870.29
6087SERPINC1 levelsGCST904705940.29
6088AHNAK levelsGCST904682610.29
6089LYN levelsGCST904698260.29
6090Reticulocyte count (UKB data field 30250)GCST904681000.29
6091Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367ECGA0003670.29
6092Concentration of small VLDL particlesGCST904998560.29
6093DTI TBSS MD Superior corona radiata RGCST903845960.29
6094CCL22 levelsGCST904685740.29
6095GASK1A levelsGCST904693060.29
6096LGALS1/LGALS8 ratioGCST903153140.29
6097AmygNuclei rh volume Paralaminar-nucleusGCST900026660.29
6098PAM levelsGCST904701560.29
6099SMAD3 levelsGCST904706770.29
6100PRSS22 levelsGCST904703410.29
6101Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247ECGA0002470.29
6102CXADR/GGT1 ratioGCST903143280.29
6103IMMT levelsGCST904696090.29
6104Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369ECGA0003690.29
6105aseg global volume CC-PosteriorGCST900026070.29
6106CD19 on IgD- CD27- B cellGCST900017320.29
6107Concentration of large VLDL particlesGCST900928750.29
6108SCARF1 levelsGCST904705360.29
6109CDC37 levelsGCST904686650.29
6110ASGR2 levelsGCST904683760.29
6111White bread likingGCST900948650.29
6112IDP dMRI TBSS MD Anterior limb of internal capsule RGCST900040430.29
6113MAPKAPK2 levelsGCST904698580.29
6114Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T414ECGU0004140.29
6115Malignant neoplasm of bronchus and lung | Malignant neoplasms of respiratory and intrathoracic organsUKBB000004250.29
6116Citrulline levelsGCST902004030.29
6117Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T347ECGA0003470.29
6118IDP dMRI TBSS L1 Superior longitudinal fasciculus RGCST900041150.29
6119Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T417ECGU0004170.29
6120NPHS2 levelsGCST904700710.29
6121Age-related hearing impairment (MTAG)GCST900121150.29
6122NAP1L4 levelsGCST904699980.29
6123Left-hemisphere somatomotor network to right-hemisphere somatomotor network white-matter structural connectivityGCST903026760.29
6124MAP4K5/TBCC ratioGCST903153850.29
6125Blood cell traits latent factor 16 (white cell)GCST905592580.29
6126IDP dMRI TBSS ICVF Superior corona radiata RGCST900043510.29
6127Other chondrocalcinosisFING000009770.29
6128Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T87ECGA0000870.29
6129Tiglylcarnitine (C5:1-DC) levelsGCST901998000.29
6130Concentration of VLDL particles (UKB data field 23428)GCST902695250.29
6131APCS levelsGCST904284630.29
6132AMBP levelsGCST904682880.29
6133CRELD2/TXNDC5 ratioGCST903142590.28
6134CFP levelsGCST904687310.28
6135NRCAM/PCDH17 ratioGCST903155530.28
6136SOST/SPP1 ratioGCST903158710.28
6137Biological Father: High cholesterolGCST904752420.28
6138F11R/GP1BA ratioGCST903147220.28
6139Metabolic syndromeGCST0096020.28
6140ADH1B levelsGCST904682430.28
6141Saturated fatty acids to total fatty acids percentageGCST905027000.28
6142Cholesteryl esters to total lipids in medium LDL percentage (UKB data field 23621)GCST902697180.28
6143CDKN1A/FOXO1 ratioGCST903139700.28
6144Omega-6 fatty acids to total fatty acids percentageGCST905025280.28
6145Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T343ECGA0003430.28
6146DTI TBSS L2 Anterior limb of internal capsule LGCST903844930.28
6147BMP10 levelsGCST904684520.28
6148T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903209270.28
6149Getting up in morning | SleepUKBB000002850.28
6150Butyrylcarnitine levelsGCST902435890.28
61512-aminobutyrate levelsGCST902435840.28
6152Cholesteryl esters to total lipids in very small VLDL percentage (UKB data field 23606)GCST902697030.28
6153Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360ECGA0003600.28
6154Operative procedures - Primary total prosthetic replacement of knee joint using cement | Summary OperationsUKBB000005880.28
6155Monounsaturated fatty acids to total fatty acids percentageGCST905020510.28
6156Cutaneous abscess, furuncle and carbuncleFING000003730.28
6157Cervical cancerGCST900118160.28
6158aparc-DKTatlas lh volume supramarginalGCST900028910.28
6159Pain in jointFING000011370.28
6160GNE levelsGCST904693700.28
6161Generalized anxiety disorderFING000005660.28
6162Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T119ECGU0001190.28
6163Free cholesterol levels in large VLDLGCST900928720.28
6164IDP T1 FAST ROIs L ventral striatumGCST900025590.28
6165Liver fatGCST905668170.28
6166DDX58 levelsGCST904689770.28
6167aparc-Desikan rh area precuneusGCST900031310.28
6168aparc-a2009s lh area Pole-temporalGCST900033390.28
6169Total lipids in small VLDLGCST904998400.28
6170Colonic or urogenital fistulaFING000003150.28
6171IDP dMRI ProbtrackX ISOVF unc lGCST900045500.28
6172Foveal thicknessGCST906241130.28
6173Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110ECGU0001100.28
6174Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167ECGA0001670.28
6175Savoury biscuit likingGCST900948340.28
6176Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T192ECGU0001920.28
6177Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T214ECGA0002140.28
6178IDP dMRI TBSS L2 Anterior limb of internal capsule RGCST900041390.28
6179Cholesterol levels in very large HDLGCST900930040.28
6180Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB000005750.28
6181ERBB4 levelsGCST904691410.28
6182TNFRSF1A levelsGCST904709100.28
6183BA-exvivo rh area BA3aGCST900032230.28
6184ATP5IF1/F2R ratioGCST903133840.28
6185Liver likingGCST900947940.28
6186DTI autoptx FA ptr l tractGCST903851310.28
6187GFER levelsGCST904693260.28
6188aparc-DKTatlas rh area precuneusGCST900032880.28
6189Frequency of depressed mood in last 2 weeks | Mental healthUKBB000002590.28
6190Triglycerides to Total Lipids in Large VLDL percentageGCST904982930.28
6191mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST904754480.28
6192Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450ECGA0004500.28
6193Paternal history of Alzheimer's diseaseGCST0059200.28
6194Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T130ECGA0001300.28
6195Impacted cerumen (PheCode 380.4)GCST904759010.28
6196IDP dMRI TBSS L2 Superior longitudinal fasciculus LGCST900041640.28
6197IDP dMRI TBSS L2 Cingulum cingulate gyrus RGCST900041570.27
6198Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365ECGA0003650.27
6199SERPINB13 levelsGCST904233260.27
6200Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T405ECGU0004050.27
6201GFRA1/TNFRSF1A ratioGCST903149240.27
6202AZU1/RNASE3 ratioGCST903134280.27
6203PLXNB3/SNAP23 ratioGCST903156930.27
6204AmygNuclei lh volume Medial-nucleusGCST900026530.27
6205GIT1 levelsGCST904693510.27
6206MIF levelsGCST900890180.27
6207ITGB1BP2/LAT2 ratioGCST903152120.27
6208EIF4G1/HEXIM1 ratioGCST903146350.27
6209Free cholesterol to total lipids in very large VLDL percentage (UKB data field 23587)GCST902696840.27
6210Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivityGCST903027450.27
6211PMVK/PRTFDC1 ratioGCST903156950.27
6212AMBP/HAVCR1 ratioGCST903132540.27
6213APOA1 levelsGCST900928080.27
6214LTA levelsGCST904698130.27
6215Raynaud's syndromeGCST904481870.27
6216BCAM/NOTCH1 ratioGCST903134740.27
6217ATP5IF1/HSPA1A ratioGCST903133880.27
6218FYB1/MESD ratioGCST903149110.27
6219FXN levelsGCST904692820.27
6220Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T133ECGA0001330.27
6221BAP18 levelsGCST904684220.27
6222IDP dMRI TBSS ICVF Retrolenticular part of internal capsule LGCST900043480.27
6223MENT levelsGCST904698860.27
6224NPPB levelsGCST904700740.27
6225BMP6/SPINT2 ratioGCST903135290.27
6226Total lipid levels in large VLDLGCST900928740.27
6227TGOLN2 levelsGCST904708500.27
6228Monounsaturated fatty acid levelsGCST905020380.27
6229Glycoprotein acetyls levelsGCST900928210.27
6230Abnormality of gait (PheCode 350.2)GCST904758410.27
6231CXCL1 levelsGCST904689300.27
6232DNMBP/PTPN1 ratioGCST903145170.27
6233QPCT/RNASET2 ratioGCST903157580.27
6234Free Cholesterol to Total Lipids in Small HDL percentageGCST904994360.27
6235FXN/TRIAP1 ratioGCST903148990.27
6236CCL18/TFPI ratioGCST903136910.27
6237Varicose veinsGCST900861440.27
6238Ceramide (d18:2/24:0) levelsGCST900240550.27
6239CLEC1B/HEXIM1 ratioGCST903140930.27
6240Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T136ECGU0001360.27
6241End-diastolic bi-ventricular shape (principal component 2)GCST904484810.27
6242SERPINB1 levelsGCST904705890.27
6243Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199ECGU0001990.27
6244IL10RB levelsGCST904695450.27
6245Non-mucinous epithelial ovarian cancerGCST902441670.27
6246CD40/CRELD2 ratioGCST903138110.27
6247TMEM106A levelsGCST904708860.27
6248Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T136ECGA0001360.27
6249Liver iron contentGCST900166740.27
6250T1 FIRST volume BrStemGCST903839890.27
6251Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144ECGU0001440.27
6252PRKAB1 levelsGCST904703240.27
6253LifespanGCST905518860.27
6254Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T293ECGU0002930.27
6255Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368ECGA0003680.27
6256Triglyceride (52:5) levelsGCST904883200.27
6257Volume of right cortico-amygdaloid transition areaGCST904749110.27
6258Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T491ECGU0004910.27
6259SNX9 levelsGCST904707030.27
6260Total concentration of lipoprotein particles (UKB data field 23427)GCST902695240.27
6261CD300LG/TNFRSF1A ratioGCST903138030.26
6262Smoking/smokers in household | SmokingUKBB000007830.26
6263MANF/PRDX5 ratioGCST903153650.26
6264PIK3IP1 levelsGCST904702340.26
6265Atrial fibrillationGCST906244120.26
6266Cholesterol in Medium LDLGCST904987030.26
6267T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 72)GCST903206350.26
6268Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T297ECGA0002970.26
6269DTI TBSS FA Retrolenticular part of internal capsule RGCST903844000.26
6270Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523FING000003040.26
6271Free cholesterol to total lipids ratio in medium HDLGCST900928970.26
6272rfMRI amplitudes (ICA100 node 30)GCST900046180.26
6273EIF4B/IPCEF1 ratioGCST903146220.26
6274TNFSF12 levelsGCST904709190.26
6275TEK levelsGCST904708290.26
6276Phospholipids in very large VLDLGCST905006440.26
6277aseg lh volume PallidumGCST900026230.26
6278GM2A levelsGCST904693650.26
6279Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435ECGU0004350.26
6280Left-hemisphere control network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027470.26
6281EPHB6/TNFRSF9 ratioGCST903146820.26
6282Breast cancerGCST904681170.26
6283Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T200ECGU0002000.26
6284Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T455ECGU0004550.26
6285Diacylglycerol_36:2_[M+H-H2O]1+ levelsGCST900601910.26
6286Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135ECGU0001350.26
6287SERPINB1/TMSB10 ratioGCST903158300.26
6288Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T289ECGU0002890.26
6289Plasma 11beta-hydroxyandrosterone glucuronide levels in chronic kidney diseaseGCST902643210.26
6290Cauliflower likingGCST900947270.26
6291Vitamin and mineral supplements - None of the above | MedicationUKBB000009010.26
6292SAMD9L levelsGCST904705240.26
6293REST UKBBICA NODEamps25 0014GCST903854970.26
6294Lysophosphatidylcholine (26:0) [sn1] levelsGCST900241880.26
6295TNFRSF19 levelsGCST904709090.26
6296Left-hemisphere visual network to accumbens white-matter structural connectivityGCST903026680.26
6297Triglycerides in very small VLDLGCST905008850.26
6298total cholesterol (maximum, inv-norm transformed)GCST904764200.26
6299Right ventricular end diastolic volume (MTAG)GCST901345920.26
6300Cardiovascular diseases (excluding rheumatic etc)FING000002550.26
6301DTI autoptx L3 cgc r tractGCST903851980.26
6302Triacylglycerol_56:4_[M+NH4]1+ levelsGCST900605560.26
6303Spread type: Butter and margarine spreads vs oil-based spreads (UKB data field 1428)GCST901329510.26
6304T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903206720.26
6305RSPO1/SFRP1 ratioGCST903157910.26
6306RNF41/WWP2 ratioGCST903157820.26
6307PLAU/PLAUR ratioGCST903156740.26
6308Average diameter for VLDL particlesGCST900930020.26
6309Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027760.26
6310CD160/CXCL16 ratioGCST903137280.26
6311CD300E/LILRA5 ratioGCST903137980.26
6312SNAP23/ZBTB16 ratioGCST903158580.26
6313Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T488ECGU0004880.26
6314RUNX3 levelsGCST902427060.26
6315GGT1/IL1RL2 ratioGCST903149290.26
6316Glycoprotein acetyls levelsGCST904973200.26
6317ELOA levelsGCST904691040.26
6318DSG2 levelsGCST904278250.26
6319Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T390ECGU0003900.26
6320CDC37/SNAP29 ratioGCST903139350.26
6321CAG-776 sp000438195 abundance in stoolGCST900322960.26
6322ITGB1/ITGB2 ratioGCST903152250.26
6323Retinal venular widthGCST902704000.26
6324CDSN/WFDC12 ratioGCST903139990.26
6325CTSH levelsGCST900885010.26
6326T1 CAT volume R InsularCortexGCST903840030.26
6327Phospholipids to total lipids ratio in small LDLGCST900929650.25
6328HDL x anxiety interaction (2df test)GCST905706650.25
6329CCL25 levelsGCST902747680.25
6330Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358ECGA0003580.25
6331Omega-3 fatty acid levelsGCST905020560.25
6332PTPN6 levelsGCST904703770.25
6333CD20 on IgD- CD24- B cellGCST900017530.25
6334APOB/APOA1 ratioGCST904971560.25
6335ENTPD6 levelsGCST904691220.25
6336Hernia of abdominal wall, postoperativeFING000006180.25
6337QC rfMRI cleaned inverse tSNRGCST900063580.25
6338Monocyte countGCST900259500.25
6339T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903209000.25
6340White blood cell countGCST900023750.25
6341Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T193ECGA0001930.25
6342Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168ECGU0001680.25
6343CRACR2A levelsGCST904688530.25
6344Phospholipids to total lipids in very small VLDL percentage (UKB data field 23604)GCST902697010.25
6345Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168ECGA0001680.25
6346ANP32B levelsGCST902401760.25
6347Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T470ECGU0004700.25
6348IDP dMRI TBSS FA Superior cerebellar peduncle RGCST900038890.25
6349NBL1/NECTIN4 ratioGCST903155140.25
6350BIN1 levelsGCST900907570.25
6351Insomnia (weighted GWA)GCST902672870.25
6352APP/LAMA4 ratioGCST903133250.25
6353ENTPD2 levelsGCST904691200.25
6354Vanillylmandelate (VMA) levelsGCST902003090.25
6355rfMRI amplitudes (ICA100 node 2)GCST900045900.25
6356FUT8 levelsGCST904692810.25
6357Cholesteryl esters to total lipids in medium HDL percentage (UKB data field 23641)GCST902697380.25
6358GBP4 levelsGCST904693130.25
6359CD58/ROR1 ratioGCST903138540.25
6360potassium (mean, inv-norm transformed)GCST904763070.25
6361Concentration of small VLDL particles (UKB data field 23509)GCST902696060.25
6362Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)GCST900419050.25
6363DNMBP levelsGCST904690230.25
6364Edema (PheCode 782.3)GCST904762720.25
6365CXCL6 levelsGCST904689330.25
6366AK1/NSFL1C ratioGCST903132240.25
6367ITGA6 levelsGCST904696360.25
6368CLEC1B/PLXNA4 ratioGCST903141000.25
6369Insomnia complaintsGCST0046950.25
6370Cholesterol in Small HDLGCST904993580.25
6371Cardiac dysrhythmias (PheCode 427)GCST904759630.25
6372Cholesterol to total lipids ratio in chylomicrons and extremely large VLDLGCST900930410.25
6373ADAM23 levelsGCST904682190.25
6374Cervical cancerGCST900185970.25
6375GC levelsGCST901625640.25
6376LEPR/NRCAM ratioGCST903153120.25
6377Duration of moderate activity | Physical activityUKBB000001970.25
6378Docosahexaenoic acid levelsGCST905022540.25
6379DLL1/EFEMP1 ratioGCST903144940.25
6380MANSC4 levelsGCST904698480.25
6381T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119)GCST903206820.25
6382HippSubfield rh volume Whole-hippocampal-bodyGCST900027090.25
6383Special factor anxiety/tension in mitochondrial haplogroup UGCST902641270.25
6384Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T165ECGA0001650.25
6385Monounsaturated fatty acids to total fatty acids percentageGCST905023720.25
6386Retinal thickness (functional principal component 5)GCST904557250.25
6387IDP dMRI ProbtrackX L2 cgc rGCST900042780.25
6388Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169ECGU0001690.25
6389CD99/PIK3IP1 ratioGCST903139290.25
6390Smoking and associated risk behaviours (confirmatory factor analysis Factor 6)GCST903093410.25
6391DLL1 levelsGCST904690040.25
6392Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363ECGA0003630.25
6393Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270ECGA0002700.25
6394Treatment speciality of consultant (recoded) - Urology | Summary AdministrationUKBB000008380.25
6395Aspartate aminotransferase (AST, minimum, inv-norm transformed)GCST904751240.25
6396RAB10 levelsGCST904704030.25
6397Congestive heart failure; nonhypertensive (PheCode 428)GCST904759810.25
6398Proline levelsGCST902434570.25
6399Triglycerides to total lipids in IDL percentage (UKB data field 23613)GCST902697100.24
6400Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246ECGA0002460.24
6401HCLS1 levelsGCST904694370.24
6402Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T288ECGU0002880.24
6403HippSubfield rh volume molecular-layer-HP-headGCST900026990.24
6404Leg fat percentage right (UKB data field 23111)GCST904681750.24
6405DAB2/ZBTB16 ratioGCST903143700.24
6406ICD10 O00: Ectopic pregnancyGCST904542270.24
6407Pain type(s) experienced in last month - Knee pain | PainUKBB000006290.24
6408ART3/RGMA ratioGCST903133620.24
6409Ectopic pregnancyGCST902728830.24
6410aparc-a2009s rh area S-centralGCST900034150.24
6411Cholesteryl Esters to Total Lipids in Very Small VLDL percentageGCST905007640.24
6412Cholesteryl esters in very large HDL (UKB data field 23555)GCST902696520.24
6413Left-hemisphere default mode network to accumbens white-matter structural connectivityGCST903027730.24
6414Left-hemisphere default mode network to caudate white-matter structural connectivityGCST903027680.24
6415Blood cell traits latent factor 4 (red cell)GCST905592460.24
6416T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14)GCST903205770.24
6417Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269ECGA0002690.24
6418Fresh fruit consumptionGCST901329790.24
6419ChalazionFING000002670.24
6420Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T201ECGU0002010.24
6421Vascular dementia (subcortical)FING000014200.24
6422Unspecified acute lower respiratory infectionFING000013980.24
6423IDP T1 FAST ROIs L precentral gyrusGCST900024630.24
6424IDP dMRI ProbtrackX OD fmaGCST900044600.24
6425Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359ECGA0003590.24
6426Principal component-derived dietary pattern 43GCST901330480.24
6427FUCA1 levelsGCST904692750.24
6428CEACAM16 levelsGCST904686890.24
6429SERPINE1/SMAD1 ratioGCST903158330.24
6430C4BPB levelsGCST904684990.24
6431RPE levelsGCST904704950.24
6432IDP dMRI TBSS OD Superior fronto-occipital fasciculus RGCST900044440.24
6433Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98ECGA0000980.24
6434IDP dMRI TBSS L1 Posterior corona radiata LGCST900041020.24
6435Triglycerides in very large VLDLGCST905006710.24
6436Cholesterol to Total Lipids in Small HDL percentageGCST904993690.24
6437BACH1 levelsGCST904684150.24
6438IL1RL2 levelsGCST904695750.24
6439ICAM5 levelsGCST902415410.24
6440IGSF21 levelsGCST904695380.24
6441ICD10 O13: Gestational hypertensionGCST904542320.24
6442Triglycerides to Total Lipids in Very Small VLDL percentageGCST905009000.24
6443Principal component-derived dietary pattern 42GCST901330470.24
6444PDGF-BB levelsGCST904284300.24
6445Cholesteryl Esters to Total Lipids in Medium LDL percentageGCST904987470.24
6446aparc-a2009s rh volume G-parietal-supGCST900030250.24
6447Activities undertaken to treat anxiety | AnxietyUKBB000000090.24
6448Phospholipids in HDLGCST904974300.24
6449FOXO1/SNAP23 ratioGCST903148750.24
6450Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165ECGU0001650.24
6451Phosphatidylglycerol (34:1) levelsGCST900250610.24
6452TGFBI levelsGCST904708450.24
6453Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595)GCST902696920.24
6454CLEC1B/GP1BA ratioGCST903140910.24
6455HealthspanGCST0074060.24
6456ADAMTS15/CLMP ratioGCST903131700.24
6457F-seafood liking (derived food-liking factor)GCST900948360.24
6458Plasma X-25279 levels in chronic kidney diseaseGCST902668350.24
6459Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T289ECGA0002890.24
6460DECR1/METAP1D ratioGCST903144480.24
6461Principal component-derived dietary pattern 27GCST901330320.24
6462RND3 levelsGCST904222300.24
6463Total diffusion tensor imaging along the perivascular space indexGCST904555460.24
6464IDP SWI T2star right putamenGCST900038680.24
6465Main speciality of consultant (recoded) - Trauma and orthopaedics | Summary AdministrationUKBB000004200.24
6466GP1BA levelsGCST904693800.24
6467ADM levelsGCST904682460.24
6468Chronic lymphocytic leukemiaGCST906247380.24
6469ENO1 levelsGCST904691090.24
6470Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T469ECGU0004690.24
6471Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T454ECGU0004540.24
6472Blood clot / pulmonary embolism / deep vein thrombosis (DVT)GCST904752090.24
6473PARP1 levelsGCST904701600.24
6474Left-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivityGCST903026610.24
6475ALPP/LAMP3 ratioGCST903132490.24
6476Histidine levelsGCST900928300.24
6477Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906687390.24
6478SCARB2 levelsGCST904705350.24
6479MenorrhagiaFING000008080.24
6480Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63ECGA0000630.24
6481COL1A1/OMD ratioGCST903141710.24
6482SNAP29/SPARC ratioGCST903158600.24
6483heart rate (HR, maximum, inv-normal transformed)GCST904763340.24
6484REST UKBBICA NET100 1212GCST903870660.24
6485Concentration of VLDL particlesGCST905002460.24
6486PPP1R12A/SKAP2 ratioGCST903157100.24
6487Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905024150.23
6488X-08402 levelsGCST902435380.23
6489Reticulocyte count | Blood countUKBB000007520.23
6490F2R levelsGCST900120100.23
6491EGFL7 levelsGCST904690830.23
6492DTNB levelsGCST904690460.23
6493Plasma 2-aminobutyrate levels in chronic kidney diseaseGCST902643390.23
6494Principal component-derived dietary pattern 16GCST901330210.23
6495Hereditary hemolytic anemias (PheCode 282)GCST904757790.23
6496CDH3/TNFRSF21 ratioGCST903139530.23
6497DTI autoptx MD str l tractGCST903852430.23
6498MITD1 levelsGCST904699100.23
6499Total lipids in IDLGCST904976010.23
6500Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152ECGU0001520.23
6501FGF23 levelsGCST900120220.23
6502IDP dMRI ProbtrackX ICVF ml lGCST900043920.23
6503EPHA4 levelsGCST904691310.23
6504Cardiac arrhythmiasFING000002480.23
6505IDP dMRI TBSS L1 Cingulum hippocampus LGCST900041120.23
6506Saturated fatty acids levelsGCST904999500.23
6507GAL levelsGCST900120620.23
6508Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596)GCST902696930.23
6509BA-exvivo lh volume V1GCST900028440.23
6510Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T247ECGU0002470.23
65111-(1-enyl-stearoyl)-GPE (p-18:0) levelsGCST901999100.23
6512Linoleic acid to total fatty acids percentage (UKB data field 23456)GCST902695530.23
6513SEMA7A levelsGCST904705750.23
6514Free cholesterol to total lipids in small HDL percentage (UKB data field 23647)GCST902697440.23
6515Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415ECGU0004150.23
6516IRAG2 levelsGCST904696260.23
6517CX3CL1/PODXL2 ratioGCST903143260.23
6518Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T283ECGU0002830.23
6519Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76ECGU0000760.23
6520Triglycerides in LDLGCST904984690.23
6521ESM1 levelsGCST900120680.23
6522OsteoarthritisGCST901342880.23
6523Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166ECGA0001660.23
6524MZB1/TNFRSF13B ratioGCST903155090.23
6525Ulcer of lower limb, not elsewhere classifiedFING000013850.23
6526CCL13/CCL8 ratioGCST903136760.23
6527Cholesterol in very large HDL (UKB data field 23554)GCST902696510.23
6528aseg rh volume HippocampusGCST900026410.23
6529Tooth agenesis EXCLUDE clefts and syndromesFING000013680.23
6530ESAM/JAM2 ratioGCST903147120.23
6531wg rh intensity-contrast transversetemporalGCST900038600.23
6532MANF/TXNDC5 ratioGCST903153700.23
6533ICD10 E28.2: Polycystic ovarian syndromeGCST904542050.23
6534FLT3/FLT3LG ratioGCST903148590.23
6535Colon polypsGCST904753190.23
6536TLR4 levelsGCST904708800.23
6537Polyunsaturated fatty acid levelsGCST905021330.23
6538LAT/VASH1 ratioGCST903152890.23
6539Volume of right central nucleusGCST904749160.23
6540Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433ECGU0004330.23
6541GSTA1/PBLD ratioGCST903149940.23
6542F-caffeinated/sweet liking (derived food-liking factor)GCST900947200.23
6543Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T395ECGU0003950.23
6544Reticulocyte fraction of red cellsGCST900024060.23
6545Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T498ECGU0004980.23
6546Cholesteryl esters to total lipids in very large HDL percentage (UKB data field 23631)GCST902697280.23
6547Leg fat percentage (left) | Impedance measuresUKBB000003910.23
6548Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T409ECGU0004090.23
6549Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T118ECGU0001180.23
6550Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T258ECGU0002580.23
6551SMTN levelsGCST904706890.23
6552Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170ECGU0001700.23
6553AAGAB levelsGCST906174730.23
6554aseg global volume CSFGCST900026030.23
6555Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154ECGU0001540.23
6556Cholesteryl ester levels in medium HDLGCST900928940.23
6557BCR levelsGCST904684360.23
6558Lysophosphatidylcholine (24:0) [sn2] levelsGCST900254260.23
6559Monounsaturated fatty acid levelsGCST905023630.23
6560aparc-pial rh area supramarginalGCST900032040.23
6561COL28A1 levelsGCST904688150.23
6562CNTN3/FETUB ratioGCST903141640.23
6563Ratio of polyunsaturated fatty acids to monounsaturated fatty acidsGCST900929400.23
6564IDP dMRI TBSS ICVF Superior cerebellar peduncle LGCST900043400.23
6565ENO2/TXNDC5 ratioGCST903146710.23
6566Fasting blood insulinGCST0051850.23
6567TNFRSF11B/TNFSF11 ratioGCST903159300.23
6568COX5B/FXN ratioGCST903141990.23
6569Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T271ECGA0002710.23
6570Treatment/medication code - gliclazide | MedicationsUKBB000008460.23
6571IDP dMRI TBSS L3 Uncinate fasciculus LGCST900042160.23
6572IDP T1 FAST ROIs L parahipp gyrus postGCST900025190.23
6573TPMT levelsGCST904709450.23
6574B3GNT7 levelsGCST904684110.23
6575HDL cholesterolGCST0022230.23
6576Inpatient record format - UK HES In Patient (2015 format) | Summary AdministrationUKBB000003640.23
6577Urinary albumin excretionGCST0065860.23
6578SULT1A1 levelsGCST904707810.23
6579Plasma 1-methylurate levels in chronic kidney diseaseGCST902642400.23
6580APLP1 levelsGCST904683300.23
6581ANGPT1/PDGFA ratioGCST903132660.23
6582CCER2 levelsGCST904685630.23
6583CST3/TIMP1 ratioGCST903143000.22
6584Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T486ECGA0004860.22
6585Left-hemisphere limbic network to putamen white-matter structural connectivityGCST903027380.22
6586Polyglandular dysfunctionFING000011860.22
6587Cholesterol to Total Lipids in Very Small VLDL percentageGCST905007310.22
6588AREG levelsGCST904683470.22
6589CLEC5A levelsGCST904687760.22
6590Systemic lupus erythematosusGCST900142380.22
6591T1 FreeSurfer DK lh superiortemporal thicknessGCST903856510.22
6592Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T90ECGA0000900.22
6593Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T243ECGA0002430.22
6594SH2B3/SUGT1 ratioGCST903158400.22
6595ADAMTS4 levelsGCST904682260.22
6596ANGPT1 levelsGCST904683000.22
6597aparc-a2009s rh volume S-parieto-occipitalGCST900030630.22
6598MMP10 levelsGCST904699150.22
6599Concentration of small HDL particlesGCST900929510.22
6600Free cholesterol in small LDLGCST904996200.22
6601DTI autoptx MD cgc l tractGCST903852240.22
6602Saturated fatty acids levelsGCST905021920.22
6603Maximum heart rate during fitness test | ECG during exerciseUKBB000004310.22
6604ITGB7 levelsGCST904696470.22
6605Subarachnoid haemorrhageFING000013390.22
6606CD63 levelsGCST904686420.22
6607Non-oily fish consumptionGCST901329940.22
6608Triglycerides to total lipids in large LDL percentage (UKB data field 23618)GCST902697150.22
6609Osteoarthritis of the hip or kneeGCST0070920.22
6610BA-exvivo lh area BA45GCST900032150.22
6611Histidine levels (UKB data field 23463)GCST902695600.22
6612TRIM40 levelsGCST904709680.22
6613LEFTY2 levelsGCST904697520.22
6614CELA3A/CTRC ratioGCST903140120.22
6615Other dorsopathies, not elsewhere classifiedFING000010410.22
6616Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128ECGU0001280.22
6617Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T139ECGA0001390.22
6618Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286ECGA0002860.22
6619Medication use (antihypertensives)GCST900187640.22
6620Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020770.22
6621Sleep apnea | neurologicalUKBB000007740.22
6622Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T490ECGA0004900.22
6623Cholesteryl ester levels in small VLDLGCST900929700.22
6624SULT2A1 levelsGCST904707820.22
6625DAG1/PDGFB ratioGCST903143790.22
6626Total Lipids in HDLGCST904974010.22
6627TNFRSF11B levelsGCST900120020.22
6628Neutrophil percentage of white cells varianceGCST905657010.22
6629Selective deficiency of immunoglobulin G [IgG] subclassesFING000012880.22
6630Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121ECGA0001210.22
6631ADM levelsGCST900119960.22
6632JAM2/TNFRSF14 ratioGCST903152400.22
6633ENG/NOTCH1 ratioGCST903146480.22
6634ESM1 levelsGCST904691530.22
6635ArthrosisFING000001110.22
6636IDP dMRI TBSS ICVF Splenium of corpus callosumGCST900043310.22
6637HAVCR2/TREM2 ratioGCST903150310.22
6638RELT/TNFRSF1A ratioGCST903157670.22
6639CLEC1B/SORT1 ratioGCST903141040.22
6640Cholesteryl esters to total lipids ratio in very small VLDLGCST900930310.22
6641Panic attacks | Mental distressUKBB000006340.22
6642MME levelsGCST904699140.22
6643Alcohol frequency weekly (standard GWA)GCST902672660.22
6644Other diseases of blood and blood-forming organsFING000009980.22
6645FABP2/LGALS4 ratioGCST903147560.22
6646F2R/SNX9 ratioGCST903147360.22
6647Other diseases of the respiratory systemFING000010110.22
6648CNPY4/ERBIN ratioGCST903141480.22
6649DTI TBSS FA Corticospinal tract RGCST903843860.22
6650DTI TBSS L3 Posterior thalamic radiation RGCST903845520.22
6651Coffee consumption (cups per day)GCST901329840.22
6652Right subiculum volume (body)GCST902679800.22
6653TRIM25 levelsGCST904709660.22
6654FCER1A levelsGCST904691980.22
6655Suppurative and unspecified otitis mediaFING000013460.22
6656IDP dMRI TBSS L1 Genu of corpus callosumGCST900040770.22
6657DNMBP/TJAP1 ratioGCST903145210.22
6658T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903206550.22
6659LRCH4 levelsGCST904697910.22
6660TIRAP levelsGCST902430320.22
6661FGFBP3 levelsGCST904692320.22
6662BA-exvivo rh thickness V2GCST900035370.22
6663IDP dMRI TBSS L1 Inferior cerebellar peduncle LGCST900040860.22
6664Height decline (difference score)GCST905658630.21
6665Migraine without aura and triptan purchasesFING000008220.21
6666Felt very upset when reminded of stressful experience in past month | Traumatic eventsUKBB000002430.21
6667Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285ECGU0002850.21
6668Cholesterol to total lipids ratio in very large VLDLGCST900930170.21
6669Benign paroxysmal vertigoFING000002100.21
6670Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T88ECGA0000880.21
6671IDP dMRI ProbtrackX ICVF fmaGCST900043850.21
6672CANT1/GSTA1 ratioGCST903136160.21
6673Phosphatidylcholine_33:4_[M+H]1+/Phosphatidylethanolamine_36:4_[M+H]1+/Phosphatidate_38:5_[M+NH4]1+ levelsGCST900602730.21
6674Cholesteryl esters in small VLDL (UKB data field 23513)GCST902696100.21
6675Other arrhythmiasFING000009620.21
6676Docosahexaenoic acid to total fatty acids percentageGCST905022840.21
6677Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T140ECGA0001400.21
6678Glutamine levelsGCST904972850.21
6679Percent liver fatGCST900166730.21
6680Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T231ECGU0002310.21
6681Hearing (confirmatory factor analysis Factor 32)GCST903093660.21
6682Concentration of medium LDL particlesGCST904988190.21
6683PDCD1/TNFRSF9 ratioGCST903156110.21
6684CCL5/TFPI ratioGCST903137080.21
6685Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142ECGU0001420.21
6686IDP dMRI TBSS L1 Splenium of corpus callosumGCST900040790.21
6687aseg rh intensity PutamenGCST900037840.21
6688ThalamNuclei lh volume PuIGCST900027140.21
6689FCGR2A levelsGCST904692000.21
6690Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T400ECGU0004000.21
6691Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T198ECGU0001980.21
6692SnoringGCST0097620.21
6693AMOTL2 levelsGCST904682940.21
6694TAFA5 levelsGCST904708000.21
6695ENO2 levelsGCST904691100.21
6696HNMT/SETMAR ratioGCST903150690.21
6697X-12749 levelsGCST902437700.21
6698PLAUR levelsGCST904702510.21
6699IGFBPL1 levelsGCST904695330.21
6700CEP20 levelsGCST904687120.21
6701CDA levelsGCST904686600.21
6702GM3 ganglioside (d18:1/24:0) levelsGCST900247290.21
6703Cholesteryl Esters in Large LDLGCST904979490.21
6704OPLAH levelsGCST904701270.21
6705Other and unspecified rosaceaFING000009510.21
6706DyslipidemiaGCST900860770.21
6707Hearing difficultyGCST900447750.21
6708Cholesterol to total lipids in large VLDL percentage (UKB data field 23590)GCST902696870.21
6709Liver volumeGCST900166660.21
6710BTD levelsGCST904684770.21
6711Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T497ECGU0004970.21
6712IDP dMRI ProbtrackX ISOVF ifo lGCST900045370.21
6713IRF3 levelsGCST906187430.21
6714Social trust (aggregated)GCST903193150.21
6715Atrial fibrillation and flutter (PheCode 427.2)GCST904759670.21
6716Polyunsaturated fatty acid levelsGCST905021420.21
6717Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T101ECGU0001010.21
6718Cholesteryl Esters to Total Lipids in Small LDL percentageGCST904995950.21
6719Left-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST903027220.21
6720Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T164ECGU0001640.21
6721Free Cholesterol to Total Lipids in Medium LDL percentageGCST904987840.21
6722IDP dMRI TBSS FA Uncinate fasciculus RGCST900039210.21
6723Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T83ECGU0000830.21
6724Plasma 16a-hydroxy DHEA 3-sulfate levels in chronic kidney diseaseGCST902643280.21
6725ThalamNuclei lh volume VAmcGCST900027230.21
6726KIAA2013 levelsGCST904696790.21
6727Myeloid white cell countGCST0046260.21
6728Smoked fish likingGCST900948410.21
6729Phosphatidylcholines levels (UKB data field 23437)GCST902695340.21
6730EDAR/ITGB1BP2 ratioGCST903145800.21
6731Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160ECGU0001600.21
6732Qualifications - CSEs or equivalent | EducationUKBB000007280.21
6733Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364ECGA0003640.21
6734Phospholipids to Total Lipids in IDL percentageGCST904976440.21
6735Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST906684850.20
6736CCL18/RARRES2 ratioGCST903136900.20
6737Dysmenorrheic pain severityGCST0066560.20
6738CD163/MARCO ratioGCST903137370.20
6739Triglyceride levels in large VLDLGCST900928780.20
6740aparc-DKTatlas lh volume pericalcarineGCST900028810.20
6741DNAJB14 levelsGCST904272350.20
6742MMP8 levelsGCST904699220.20
6743PPM1B levelsGCST904702960.20
6744Other arthrosisFING000009650.20
6745FABP1/RBP2 ratioGCST903147530.20
6746Dermatitis due to ingested foodFING000004030.20
6747Spread type - Other type of spread/margarine | DietUKBB000007950.20
6748XPNPEP2 levelsGCST904710840.20
6749Platelet count at deliveryGCST903022270.20
6750Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451ECGA0004510.20
6751Non-cancer illness code, self-reported - depression | Medical conditionsUKBB000005070.20
6752Phospholipids to total lipids in medium HDL percentage (UKB data field 23639)GCST902697360.20
6753CA5A/GRPEL1 ratioGCST903135900.20
6754NFATC1 levelsGCST904700330.20
6755IPCEF1/TBCB ratioGCST903151870.20
6756Valine levelsGCST905001770.20
6757Cholesterol in Small HDLGCST904993480.20
6758CPM/PCSK9 ratioGCST903142160.20
6759SPRR3 levelsGCST904707370.20
6760Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468ECGU0004680.20
6761MFGE8 levelsGCST904699000.20
6762DOK2/PPP1R12A ratioGCST903145360.20
6763BIN2/FYB1 ratioGCST903135050.20
6764GFRA2 levelsGCST904693290.20
6765Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T416ECGU0004160.20
6766Concentration of medium HDL particlesGCST900928990.20
6767GFER/TRIAP1 ratioGCST903149210.20
6768Carnitine levelsGCST902399910.20
6769Total lipid levels in VLDLGCST900929990.20
6770wg lh intensity-contrast rostralmiddlefrontalGCST900038180.20
6771aparc-a2009s rh area S-intrapariet+P-transGCST900034260.20
6772KAZALD1 levelsGCST904696650.20
6773PEAR1 levelsGCST904702040.20
6774Radiotherapy (PheCode 196)GCST904756050.20
6775Omega-3 fatty acids to total fatty acids percentageGCST905024670.20
6776IDP dMRI TBSS MO Posterior corona radiata RGCST900039780.20
6777Phospholipids in LDLGCST904984390.20
6778IDP T1 SIENAX CSF normalised volumeGCST900024280.20
6779Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T60ECGU0000600.20
6780Right ventricular ejection fractionGCST902681170.20
6781Benign neoplasm of eye, uveal (PheCode 224.1)GCST904756290.20
6782DBNL/DNAJA2 ratioGCST903144150.20
6783ACY1 levelsGCST904682120.20
6784Clinical LDL cholesterol levelsGCST904972230.20
6785Anal and rectal conditions | digestiveUKBB000000290.20
6786wg rh intensity-contrast banksstsGCST900038280.20
6787KIAA0319 levelsGCST904696760.20
6788Chronic diseases of tonsils and adenoidsFING000002830.20
6789GRAP2/PLPBP ratioGCST903149840.20
6790TFRC levelsGCST904516840.20
6791Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8 (more control exclusions)FING000006940.20
6792Total body bone mineral density (age 0-15)GCST0053450.20
6793Concentration of small HDL particlesGCST904994610.20
6794Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T489ECGA0004890.20
6795PALM3 levelsGCST904701530.20
6796Free Cholesterol in LDLGCST904983880.20
6797Total lipids in small VLDL (UKB data field 23510)GCST902696070.20
6798NCF2 levelsGCST904700060.20
6799RNF43 levelsGCST904704860.20
6800Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T284ECGU0002840.20
6801Androstenediol (3beta,17beta) disulfate (1) levelsGCST901998420.20
6802BA-exvivo lh area BA4pGCST900032120.20
6803Free cholesterol to total lipids ratio in large HDLGCST900928490.20
6804Neutrophill count (UKB data field 30140)GCST904680920.20
6805Free Cholesterol in VLDLGCST905002210.20
6806Disorders of vestibular function (Vertigo)FING000004640.20
6807Plasma methylsuccinate levels in chronic kidney diseaseGCST902655060.20
6808Phospholipids to Total Lipids in Small LDL percentageGCST904996900.20
6809Bell's palsyFING000001440.20
6810Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T183ECGA0001830.20
6811Urine 3-hydroxyindolin-2-one sulfate levels in chronic kidney diseaseGCST902645080.20
6812Depression/anxiety (standard GWA)GCST902672760.20
6813CASP2 levelsGCST904685440.20
6814CHMP1A levelsGCST904687460.20
6815DAG1/PDGFA ratioGCST903143780.20
6816Free cholesterol to total lipids in small LDL percentage (UKB data field 23627)GCST902697240.20
6817APP/PPP1R12A ratioGCST903133300.20
6818CD300C levelsGCST904686200.20
6819Parental longevity (father's age at death)GCST0067000.20
6820Gonarthrosis, primary, with knee surgeryFING000005860.20
6821Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T167ECGU0001670.20
6822Otitis externaFING000011280.20
6823Systolic blood pressure, manual reading, adjusted by medication | Cardiovascular measurementUKBB000008110.20
6824CST3/RETN ratioGCST903142970.20
6825Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T130ECGU0001300.20
6826Alanine levelsGCST902435820.20
6827Triacylglycerol_52:2_[M+NH4]1+ levelsGCST900605110.20
6828Octadecanedioylcarnitine (C18-DC) levelsGCST901999920.20
6829IntelligenceGCST0043640.20
6830BCAM/EPO ratioGCST903134710.20
6831MAD1L1/POLR2F ratioGCST903153540.20
6832Cleft hard palate NOSFING000003060.20
6833CST3/TAFA5 ratioGCST903142980.19
6834Prescriptions - orlistat | lipase inhibitor,obesityUKBB000006950.19
6835Prescriptions - lipase inhibitor|obesityUKBB000006880.19
6836Asthma and allergyFING000001150.19
6837HTRA2/SIAE ratioGCST903150970.19
6838FBP1/GSTA1 ratioGCST903147860.19
6839EBAG9/TGFB1 ratioGCST903145700.19
6840aparc-a2009s rh area S-oc-temp-med+LingualGCST900034310.19
6841Phospholipids to total lipids ratio in IDLGCST900928400.19
6842Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T169ECGA0001690.19
6843BTN2A1/IL18BP ratioGCST903135450.19
6844THBD levelsGCST900120480.19
6845NPPC levelsGCST904700750.19
6846IDP dMRI TBSS MD Posterior limb of internal capsule LGCST900040460.19
6847Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T88ECGU0000880.19
6848Cholesteryl Esters in HDLGCST904973570.19
6849Hyperparathyroidism (PheCode 252.1)GCST904756930.19
6850AMBN levelsGCST904682870.19
6851Ulcerative rectosigmoiditisFING000013940.19
6852Neuroticism score | Mental healthUKBB000004960.19
6853KLK10 levelsGCST904696960.19
6854CLEC4A levelsGCST904687710.19
6855TPK1 levelsGCST904709430.19
6856SEMA3F levelsGCST904705700.19
6857LY6D levelsGCST904698210.19
6858Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117ECGU0001170.19
6859Pregnancy hypertensionFING000012040.19
6860Cholesteryl ester levels in chylomicrons and extremely large VLDLGCST905009430.19
6861IDP dMRI TBSS ICVF Tapetum RGCST900043730.19
6862Exposure to tobacco smoke at home | SmokingUKBB000002280.19
6863Cognition and processing speed (confirmatory factor analysis Factor 34)GCST903093680.19
6864Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T288ECGA0002880.19
6865Left ventricular end diastole inferolateral wall thicknessGCST902785160.19
6866Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levelsGCST900257350.19
6867CASP3/SERPINB9 ratioGCST903136420.19
6868aparc-Desikan lh volume pericalcarineGCST900027880.19
6869IMPA1 levelsGCST904696100.19
6870Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T155ECGU0001550.19
6871Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141ECGU0001410.19
6872Metabolic disordersFING000008160.19
6873aseg rh volume PallidumGCST900026400.19
6874Phospholipids in large LDLGCST904980490.19
6875PCDH17/THBD ratioGCST903156070.19
6876aparc-Desikan rh volume pericalcarineGCST900028210.19
6877Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T257ECGU0002570.19
6878DTI TBSS L3 External capsule LGCST903845570.19
6879FKBP5 levelsGCST904692440.19
6880Adhesive capsulitis of shoulderFING000000430.19
6881Gout, strict definitionFING000005880.19
6882Postmenopausal breast cancerGCST904281160.19
6883Total cholesterol levels in medium VLDLGCST901326890.19
6884FCRL3 levelsGCST904692070.19
6885Prescriptions - doxazosin | alpha1-antagonist,alpha blockerUKBB000006790.19
6886Triglycerides to total lipids ratio in very large HDLGCST900930150.19
6887Glomerular diseasesFING000005810.19
6888Lysophosphatidylcholine (26:0) [sn1] levelsGCST900254270.19
6889aseg rh volume Lateral-VentricleGCST900026330.19
6890aseg lh intensity PutamenGCST900037700.19
6891MMP12 levelsGCST900120700.19
68923-Hydroxybutyrate levelsGCST900928110.19
6893Cholesteryl esters to total lipids ratio in large VLDLGCST900928710.19
6894Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivityGCST903026480.19
6895CD83/HAVCR2 ratioGCST903139040.19
6896Free cholesterol to total lipids ratio in very large VLDLGCST900930210.19
6897SPESP1 levelsGCST904707200.19
6898Free Cholesterol to Total Lipids in Medium HDL percentageGCST904985830.19
6899SEPTIN8 levelsGCST904705780.19
6900Other embolism and thrombosisFING000010430.19
6901Platelet count during second trimester of pregnancyGCST903022250.19
6902Type 1 diabetesGCST900187050.19
6903Cholesterol to total lipids in IDL percentage (UKB data field 23610)GCST902697070.19
6904Dimethylglycine levelsGCST902004240.19
6905Sphingomyelins levels (UKB data field 23438)GCST902695350.19
6906AGR2 levelsGCST904682530.19
6907T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92)GCST903209110.19
6908Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T453ECGU0004530.19
6909Polyunsaturated fatty acids to monounsaturated fatty acids ratioGCST905025550.19
6910Phospholipids in medium LDLGCST904988320.19
6911Average diameter for VLDL particlesGCST905002900.19
6912HAVCR2 levelsGCST904215150.19
6913IDP dMRI ProbtrackX L2 cgc lGCST900042770.19
6914Endometriosis of pelvic peritoneumFING000005020.19
6915Cholesteryl Esters to Total Lipids in Small VLDL percentageGCST904998000.19
6916Arterial embolism and thrombosis of lower extremity arteryFING000001060.19
6917IDP dMRI ProbtrackX L1 atr rGCST900042490.19
6918Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268ECGA0002680.19
6919C1QA levelsGCST904684850.19
6920Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T215ECGA0002150.19
6921TREML2 levelsGCST904709620.19
6922Pilonidal cystFING000011670.18
6923Coffee type: Instant coffee (UKB data field 1508_2)GCST900418020.18
6924Cylindrical power (right) | AutorefractionUKBB000001620.18
6925Total Phosphatidylcholine levelsGCST900252040.18
6926Polyunsaturated fatty acid levelsGCST905026220.18
6927Heart failureGCST903997120.18
6928Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T224ECGA0002240.18
6929Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158ECGU0001580.18
6930BA-exvivo rh area BA3bGCST900032240.18
6931CANT1 levelsGCST904685360.18
6932IDP T1 SIENAX CSF unnormalised volumeGCST900024290.18
6933Linoleic acid levelsGCST904983060.18
6934Concentration of medium HDL particlesGCST904986170.18
6935Job involves heavy manual or physical work | EmploymentUKBB000003830.18
6936ACE2/GGT1 ratioGCST903131530.18
6937SARG levelsGCST904705260.18
6938Open wounds of extremities (PheCode 871)GCST904762850.18
6939IDP T1 FIRST left caudate volumeGCST900024380.18
6940Atrial fibrillation (PheCode 427.21)GCST904759700.18
6941wg lh intensity-contrast pericalcarineGCST900038120.18
6942Brainstem global volume PonsGCST900027650.18
6943ADGRF5 levelsGCST904682390.18
6944CCS levelsGCST904685940.18
6945CETN2/TDRKH ratioGCST903140310.18
6946Methionine sulfone levelsGCST901999610.18
6947EREG/ITGB1BP2 ratioGCST903147030.18
6948F2R/SERPINE1 ratioGCST903147350.18
6949Free cholesterol in small LDLGCST904996170.18
69501-methylhistidine metabolite levelGCST906154800.18
6951Gut bacterial pathway abundance (PYRIDNUCSYN.PWY..NAD.biosynthesis.I..from.aspartate.)GCST900276380.18
6952PROK2 levelsGCST906170730.18
69531-stearoyl-2-linoleoyl-GPI (18:0/18:2) levelsGCST902000670.18
6954DTI TBSS MD Posterior thalamic radiation RGCST903846000.18
6955Treatment/medication code - ramipril | MedicationsUKBB000008560.18
6956Triglyceride to HDL cholesterol ratioGCST902959530.18
6957Degree of unsaturationGCST905027370.18
6958F-small fish liking (derived food-liking factor)GCST900948400.18
6959Phospholipids to Total Lipids in Large LDL percentageGCST904980580.18
6960EPHB4/ESAM ratioGCST903146790.18
6961Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T166ECGU0001660.18
6962Saturated fatty acids to total fatty acids percentageGCST904999660.18
6963Ximenoylcarnitine (C26:1) levelsGCST902001490.18
6964CD274 levelsGCST902748320.18
6965SOD3 levelsGCST904707060.18
6966AIFM1 levelsGCST904682680.18
6967Omega-3 fatty acid levelsGCST905024220.18
6968Benign neoplasm: Sigmoid colonFING000002030.18
6969STK24/TDRKH ratioGCST903158930.18
6970Dissection of aortaFING000004670.18
6971Cholesterol in small HDL (UKB data field 23575)GCST902696720.18
6972Phospholipids in medium LDLGCST904988310.18
6973ROR1/TNFRSF21 ratioGCST903157870.18
6974Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T61ECGU0000610.18
6975Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T451ECGU0004510.18
6976DBI/TMSB10 ratioGCST903144140.18
6977IDP dMRI TBSS ICVF Inferior cerebellar peduncle LGCST900043380.18
6978LCN2/RETN ratioGCST903153080.18
6979Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T216ECGA0002160.18
6980Free cholesterol levels in small VLDLGCST900929720.18
6981Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T398ECGU0003980.18
6982DTI TBSS FA Anterior corona radiata RGCST903844020.18
6983ITGB1BP2 levelsGCST904696420.18
6984Phosphatidylcholine diacyl C36:4 levelsGCST902400400.18
6985Presence of other functional implants | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000007090.18
6986Sphingomyelin_39:1_[M+H]1+ levelsGCST900603280.18
6987Superficial cellulitis and abscess (PheCode 681)GCST904761650.18
6988AXL/CD163 ratioGCST903134180.18
6989TTN levelsGCST904709840.18
6990Spells in hospital | Summary AdministrationUKBB000007890.18
6991Principal component-derived dietary pattern 7GCST901330120.18
6992Abnormal results of function study of thyro (PheCode 246.7)GCST904756540.18
6993CD46/SIAE ratioGCST903138350.18
6994RGMB levelsGCST904704640.18
6995Total cholines levels (UKB data field 23436)GCST902695330.18
6996CSF2RB levelsGCST904688830.18
6997Total bilirubin levels (UKB data field 30840)GCST904681040.18
6998Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T401ECGU0004010.18
6999LCP1 levelsGCST904697480.18
7000Temporomandibular joint disordersFING000013540.18